Cellular FLICE-inhibitory protein: an attractive therapeutic target?
about
Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosisLesser-Known Molecules in Ovarian Carcinogenesisc-FLIP, a master anti-apoptotic regulatorThe heme oxygenase-1 and c-FLIP in acute myeloid leukemias: two non-redundant but mutually exclusive cellular safeguards protecting cells against TNF-induced cell death?Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.Cellular stress responses: cell survival and cell deathFLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activationDifferential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.Expression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortexTRAIL in cancer therapy: present and future challenges.Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury.Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussionTargeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.cFLIP is critical for oligodendrocyte protection from inflammationModulation of apoptosis as a target for liver disease.Hyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion.Computational systems biology in cancer: modeling methods and applications.Valproate activates the Notch3/c-FLIP signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life?Hyperoxia sensing: from molecular mechanisms to significance in disease.Cellular FLICE-Inhibitory Protein Regulates Tissue Homeostasis.Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligands.Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.Regulation of cell death in cancer-possible implications for immunotherapy.CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis.Simultaneous induction of apoptosis and necroptosis by Tanshinone IIA in human hepatocellular carcinoma HepG2 cells.Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFα-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein.Evasion of apoptosis as a cellular stress response in cancer.Betulinic Acid for cancer treatment and prevention.Release of c-FLIP brake selectively sensitizes human cancer cells to TLR3-mediated apoptosis
P2860
Q24682686-3153474D-79A6-436A-94F8-C2029BD6D9EEQ26784533-62C599B2-849F-40FD-849E-ED3434BE499EQ28391119-99F43295-ED56-4DBD-8036-91593A31E4C1Q28391201-AF9BFF95-5E5C-479D-81FB-CCD1ED4B5321Q31120918-7EE0094E-7605-4832-8C78-BD3C948552ABQ33544118-7FF2C9E6-90B8-4A3E-B6E4-244580BB9553Q33674213-36FAC026-484C-4178-A79E-2FA681C55102Q33837045-5D4EEEED-601A-4138-B645-FB1CCE78A0E3Q33999606-9279BF15-3F10-497D-B9B2-7FE42B68D126Q34099046-429305AD-3EB7-4885-9C07-9BD1CED5E672Q34291312-03D9F28C-23CA-4C7D-B066-C3B37E5C5446Q34449938-25560725-AB1B-4D13-B79C-02DDD40DECBAQ35219775-B51AD55C-F7C0-4568-B9F7-C4D847303562Q35480734-E2C00101-E1E3-4B45-AF06-9DB72D87CBA2Q35762274-56890859-D16E-41AE-ABE8-CB598ED31D41Q35941480-24852D27-6914-4F8A-AA10-F4DDB43CCB32Q36066290-54CAB725-265A-4BB5-A639-1A51AF00C295Q36347312-8CFECAB4-CD0C-41EF-8B36-8E19877E3A51Q37380580-1B5BEF66-D419-4FCF-BF55-7DD3E745924FQ37459784-952D2EB6-734D-44B0-A8F9-F7B12D032C54Q37768423-4866E842-342B-4D18-AB68-F4013E9E052AQ38544605-76C7937E-0256-4A1B-9660-96910BACFBC9Q39228077-420113E4-E67F-453F-9674-00F6F8CC50C6Q39410061-D7E9C56D-0ED4-4CB7-AC3B-58E7D956C00DQ39461469-021BAC56-BFBB-49F2-8525-F3533EFC48DBQ40282121-74D3350D-4A32-4BC2-A323-C4038FD076CBQ40516096-F6497BDC-B618-479E-9F4B-81CDC64B7F15Q41266236-2D012758-DE05-4607-B333-756A7F03599AQ41482547-0707C564-4F2C-4249-AA75-CB64F8BA87FAQ41788901-20C8CB39-A919-48B0-8011-BDFC9118697CQ43159091-E0A6B158-DFC8-4B23-9323-369FC54CF743Q58695329-EC857547-425B-490D-A18B-F7ACAE9BEC07
P2860
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
@ast
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
@en
type
label
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
@ast
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
@en
prefLabel
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
@ast
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
@en
P2860
P356
P1476
Cellular FLICE-inhibitory protein: an attractive therapeutic target?
@en
P2093
Olivier Micheau
P2860
P304
P356
10.1517/14728222.7.4.559
P407
P577
2003-08-01T00:00:00Z